PA
ABBV icon

Pineridge Advisors’s AbbVie ABBV Stock Holding History

Pineridge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$112K Sell
485
-59
-11% -$12K 0.03% 70
2025
Q2 		$101K Buy
544
+93
+21% +$17.3K 0.04% 76
2025
Q1 		$94.5K Sell
451
-569
-56% -$111K 0.04% 81
2024
Q4 		$181K Buy
1,020
+79
+8% +$14.5K 0.07% 57
2024
Q3 		$186K Sell
941
-4
-0.4% -$747 0.07% 61
2024
Q2 		$162K Buy
945
+32
+4% +$5.3K 0.06% 69
2024
Q1 		$166K Sell
913
-254
-22% -$43.8K 0.06% 64
2023
Q4 		$181K Buy
+1,167
New +$170K 0.06% 76

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pineridge Advisors's ABBV Position: Q3 2025 in Review

Pineridge Advisors reduced its AbbVie (ABBV) stake by 11% in Q3 2025, selling an estimated $12K and leaving 485 shares worth $112K. The position accounts for 0.03% of the portfolio, ranked #70.

Pineridge Advisors first reported a position in ABBV in Q4 2023 and has held it in 8 quarters since. The position peaked at $186K in Q3 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Pineridge Advisors held 485 shares of AbbVie worth $112K as of Q3 2025.
  • Pineridge Advisors sold 59 AbbVie shares in Q3 2025, an estimated $12K.
  • AbbVie made up 0.03% of Pineridge Advisors's portfolio in Q3 2025, its #70 holding.
  • Pineridge Advisors first reported a position in AbbVie in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's AbbVie position peaked at $186K in Q3 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.